ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,300.00
+340.00 (5.70%)
Last updated: Oct 10, 2025, 2:02 PM KST
5.70%
Market Cap440.48B
Revenue (ttm)765.75M
Net Income (ttm)-6.16B
Shares Out73.91M
EPS (ttm)-98.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,689,077
Average Volume2,820,998
Open6,120.00
Previous Close5,960.00
Day's Range5,980.00 - 6,400.00
52-Week Range4,455.00 - 8,300.00
Betan/a
RSI54.25
Earnings Daten/a

About ImmuneOncia Therapeutics

ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer. It develops IMC-001, a human monoclonal antibody of the IgG1 type that targets PD-L1 an immunotherapy for cancer, which is in Phase II clinical trial for the treatment of NK/T cell lymphoma and solid cancer patients with high tumor mutation burden; and IMC-002, a human monoclonal antibody of the IgG4 type targeting human CD47, which is in Phase I a clinical trial for the treatment of solid cancers, su... [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 424870
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.